Teva to Donate Potential COVID-19 Treatment,
Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide Market Watch ^ | 03/19/2020
Posted on 3/19/2020, 6:23:16 PM by SeekAndFind
Teva Pharmaceutical Industries Ltd. (nyse and tase:TEVA) announced today the immediate donation of more than 6 million doses of hydroxychloroquine sulfate tablets through wholesalers to hospitals across the U.S. to meet the urgent demand for the medicine as an investigational target to treat COVID-19. The company is also looking at additional ways to address the global need.
Bayer is also now shipping their whole supply on hand as well.
Mylan Ramps Up US Manufacturing of Hydroxychloroquine Sulfate Tablets to Meet Potential COVID-19 Patient Needs
PR Newswire·8 hours ago
Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide
Yahoo Finance·3 hours ago
Mylan restarts production of potential COVID-19 treatment in West Virginia
The Business Journals·7 hours ago